The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
91718164 9171816 4 F 20130101 20160722 20130319 20160805 EXP GB-PFIZER INC-2013003842 PFIZER 65.00 YR F Y 64.60000 KG 20160805 OT GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
91718164 9171816 1 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 UNK U 0
91718164 9171816 2 PS Doxorubicin DOXORUBICIN 1 Unknown UNK U 50467
91718164 9171816 3 SS VINCRISTINE SULFATE. VINCRISTINE SULFATE 1 Unknown UNK U 71484 SOLUTION FOR INJECTION
91718164 9171816 4 SS RITUXIMAB RITUXIMAB 1 Intravenous (not otherwise specified) 667.5 MG, EVERY 3 WEEKS B6214 0 667.5 MG Q3W
91718164 9171816 5 SS RITUXIMAB RITUXIMAB 1 UNK 0
91718164 9171816 6 SS PREDNISONE. PREDNISONE 1 Unknown UNK U 0
91718164 9171816 7 C DOSULEPIN HYDROCHLORIDE DOTHIEPIN HYDROCHLORIDE 1 0
91718164 9171816 8 C ZOPICLONE ZOPICLONE 1 0
91718164 9171816 9 C PENICILLIN V PENICILLIN V 1 UNK 0
91718164 9171816 10 C VITAMIN D CHOLECALCIFEROL 1 0
91718164 9171816 11 C FYBOGEL PLANTAGO OVATA SEED 1 UNK 0
91718164 9171816 12 C SENNA SENNA LEAFSENNOSIDESSENNOSIDES A AND B 1 UNK 0
91718164 9171816 13 C LAXIDO POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE 1 UNK 0
91718164 9171816 14 C RANITIDINE. RANITIDINE 1 UNK 0
91718164 9171816 15 C OMEPRAZOLE. OMEPRAZOLE 1 UNK 0
91718164 9171816 16 C GAVISCON ALUMINUM HYDROXIDEMAGNESIUM CARBONATE 1 UNK 0
91718164 9171816 17 C FLUCONAZOLE. FLUCONAZOLE 1 UNK 0
91718164 9171816 18 C PHENOXYMETHYLPENICILLIN PENICILLIN V 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
91718164 9171816 1 B-cell lymphoma
91718164 9171816 2 B-cell lymphoma
91718164 9171816 3 B-cell lymphoma
91718164 9171816 4 B-cell lymphoma
91718164 9171816 6 B-cell lymphoma
91718164 9171816 7 Depression
91718164 9171816 8 Prophylaxis
91718164 9171816 9 Splenectomy
91718164 9171816 11 Constipation
91718164 9171816 12 Constipation
91718164 9171816 13 Constipation
91718164 9171816 14 Dyspepsia
91718164 9171816 15 Dyspepsia
91718164 9171816 16 Dyspepsia
91718164 9171816 17 Oesophageal discomfort
91718164 9171816 18 Splenectomy

Outcome of event

Event ID CASEID OUTC COD
91718164 9171816 LT
91718164 9171816 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
91718164 9171816 Febrile neutropenia
91718164 9171816 Neutropenic sepsis
91718164 9171816 Pulmonary embolism

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
91718164 9171816 4 20121017 0
91718164 9171816 9 20120323 0
91718164 9171816 11 201210 0
91718164 9171816 12 201210 0
91718164 9171816 13 20121026 0
91718164 9171816 14 20121026 20130130 0
91718164 9171816 15 20130131 0
91718164 9171816 16 20130129 20130206 0
91718164 9171816 17 20130131 20130206 0
91718164 9171816 18 20160323 0